Novartis announces collaboration with Molecular Partners to develop two DARPin therapies designed for potential use against COVID-19 - Seite 6

Nachrichtenquelle: globenewswire
28.10.2020, 07:15  |  150   |   |   

Diesen Artikel teilen
Seite 6 von 5
Wertpapier



0 Kommentare

Schreibe Deinen Kommentar

Bitte melden Sie sich an, um zu kommentieren. Anmelden | Registrieren

 

Disclaimer

Novartis announces collaboration with Molecular Partners to develop two DARPin therapies designed for potential use against COVID-19 - Seite 6 Novartis has been granted an option to in-license global rights of MP0420 and MP0423 - multi-targeted direct acting antiviral therapeutic candidates demonstrating potential efficacy against COVID-19MP0420 and MP0423 are potential medicines with a …

Community

Nachrichten des Autors

Titel
Titel
Titel
Titel